Dergiler / European Journal of Rheumatology / 2018 / Cilt: 5 - Sayı: 1

Investigation of the role of interleukin-1 receptor antagonist VNTR variant on the Behçet’s disease

Sayfa
27–31
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, further studies of this variant with larger samplesizes and different ethnicities are required for confirmation.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Behçet’s disease (BD), a chronic multisystem inflammatory disorder, is mainly characterizedby relapsing periods of a wide range of clinical symptoms.
📊
Temel Bulgular & Veri:Therefore, interleukin-1 receptor antagonist (IL-1Ra) gene 86bp variablenumber tandem repeat (VNTR) variant was investigated in patients with BD in a Turkish population.Methods: One hundred nine patients (60 females, 49 males; the mean age±standard deviation [SD]was 36.56±9.571 years) with BD and one hundred healthy individuals (54 females, 46 males; the meanage±SD was 36.64±2.294 years) were examined in the study.
💡
Sonuç & Katkı:However, further studies of this variant with larger samplesizes and different ethnicities are required for confirmation.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Behçet’s disease (BD), a chronic multisystem inflammatory disorder, is mainly characterizedby relapsing periods of a wide range of clinical symptoms. Several cytokine genes may play importantroles in the pathogenesis of BD. Therefore, interleukin-1 receptor antagonist (IL-1Ra) gene 86bp variablenumber tandem repeat (VNTR) variant was investigated in patients with BD in a Turkish population.Methods: One hundred nine patients (60 females, 49 males; the mean age±standard deviation [SD]was 36.56±9.571 years) with BD and one hundred healthy individuals (54 females, 46 males; the meanage±SD was 36.64±2.294 years) were examined in the study. For genotyping, polymerase chain re-action-restriction fragment length polymorphism analysis was employed. Data were analyzed usingStatistical Package for Social Sciences (SPSS) 22.0 (IBM Corp.; Armonk, NY, USA) (p0.05). The frequency of the a1/a1, a1/a2 geno-types and a1, a2 alleles were the most common both in patients and healthy controls (p=0.37, p=0.26,and p=0.53, respectively). Also, no statistically significant difference was found between the IL-1RaVNTR variant genotypes and clinical characteristics (p>0.05).Conclusion: The results of this study do not support an association between the IL-1Ra VNTR variantand the risk of BD in a Turkish population. However, further studies of this variant with larger samplesizes and different ethnicities are required for confirmation.

🔖

Bu Makaleye Atıf Yap

DEMİR, O., KARAKUŞ, N., YİĞİT, S., DEMİR, H. D., NURSAL, A. F., DURSUN, G. (2022). Investigation of the role of interleukin-1 receptor antagonist VNTR variant on the Behçet’s disease. European Journal of Rheumatology, Cilt: 5 - Sayı: 1, 27–31. https://ajindex.com/articles/511678

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Akyol L, Gunbey E, Karlı R, Onem S, Ozgen M, Sayarlıoglu M. Evaluation of olfactory function in Behçet's disease. Eur J Rheumatol 2016; 3: 153-6. [CrossRef] Kapsimali VD, Kanakis MA, Vaiopoulos GA, Ka- klamanis PG. Etiopathogenesis of Behcet'sdisease with emphasis on the role of immuno- logical aberrations. Clin Rheumatol 2010; 29: 1211-6. [CrossRef] Mohammad A, Mandl T, Sturfelt G, Segelmark M. Incidence, prevalence and clinical charac- teristics of Behcet's disease in southern Swe- den. Rheumatology (Oxford) 2013; 52: 304-10. [CrossRef] Zierhut M, Mizuki N, Ohno S, Inoko H, Gul A, Onoe K, et al. Immunology and functional ge- nomics of Behcet's disease. Cell Mol Life Sci 2003; 60: 1903-22. [CrossRef] Meng Q, Guo H, Hou S, Jiang Z, Kijlstra A, Yang P. Lack of an association of PD-1 and its ligand genes with Behcet's disease in a Chinese Han popula- tion. PLoS One 2011; 6: e25345. [CrossRef] Gul A. Behcet's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001; 19: 6-12.
  2. Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleu- kin-1 alpha, interleukin-1 beta, andinterleukin-1 receptor antagonist genes. Genomics 1994; 19: 382-4. [CrossRef] Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al. Polymor- phism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86- bp tandem repeat. Hum Genet 1993; 91: 403-4. [CrossRef] Dinarello CA. Interleukin-1, interleukin-1 recep- tors and interleukin-1 receptor antagonist. Int Rev Immunol 1998; 16: 457-99. [CrossRef] International study group for Behcet's disease. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335: 1078-80.
  3. Dehghanzadeh R, Babaloo Z, Sakhinia E, Khaba- zi A, Shanehbandi D, Sadigh-Eteghad S, et al. IL-27 Gene Polymorphisms in Iranian Patients with Behcet's Disease. Clin Lab 2016; 62: 855- 61. [CrossRef] Yalcin B, Atakan N, Dogan S. Association of in- terleukin-23 receptor gene polymorphism with Behçet disease. Clin Exp Dermatol 2014; 39: 881-7. [CrossRef] Wu Z, Zheng W, Xu J, Sun F, Chen H, Li P, et al. IL10 polymorphisms associated with Behçet's disease in Chinese Han. Hum Immunol 2014; 75: 271-6. [CrossRef] Hu J, Hou S, Zhu X, Fang J, Zhou Y, Liu Y, et al. In- terleukin-10 gene polymorphisms are associat- ed with Behcet's disease but not with Vogt-Koy- anagi-Harada syndrome in the Chinese Han population. Mol Vis 2015; 21: 589-603. Dinarello CA. Biologic basis for Interleukin-1 in disease. Blo